Advanced glycation end product (AGE)-AGE receptor (RAGE) system upregulated connexin43 expression in rat cardiomyocytes via PKC and Erk MAPK pathways

International Journal of Molecular Sciences

Volumn 14, Issue 2, 2013, Pages 2242-2257

  Yu, Lu ^a   Zhao, Yanbo ^a   Xu, Shengjie ^a   Ding, Fang ^a   Jin, Chongying ^a   Fu, Guosheng ^a   Weng, Shaoxiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Advanced glycation end product; Cardiomyocytes; Connexin43; Diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CONNEXIN 43; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; GAP JUNCTION; GENETIC TRANSFECTION; HEART; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84875097566     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14022242     Document Type: Article

References (48)

1. Howarth, F.C.; Shafiullah, M.; Adeghate, E.; Ljubisavljevic, M.; Jacobson, M. Heart rhythm disturbances in the neonatal alloxan-induced diabetic rat. Pathophysiology 2011, 18, 185-192.
2. Shaw, R.M.; Rudy, Y. Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ. Res. 1997, 81, 727-741.
3. Kleber, A.G.; Rudy, Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol. Rev. 2004, 84, 431-488.
4. Vozzi, C.; Dupont, E.; Coppen, S.R.; Yeh, H.I.; Severs, N.J. Chamber-related differences in connexin expression in the human heart. J. Mol. Cell. Cardiol. 1999, 31, 991-1003.
5. Das Evcimen, N.; King, G.L. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol. Res. 2007, 55, 498-510.
6. Yu, L.; Zhao, Y.; Fan, Y.; Wang, M.; Xu, S.; Fu, G. Epigallocatechin-3 gallate, a green tea catechin, attenuated the downregulation of the cardiac gap junction induced by high glucose in neonatal rat cardiomyocytes. Cell. Physiol. Biochem. 2010, 26, 403-412.
7. Lin, H.; Ogawa, K.; Imanaga, I.; Tribulova, N. Remodeling of connexin 43 in the diabetic rat heart. Mol. Cell. Biochem. 2006, 290, 69-78.
8. Howarth, F.C.; Chandler, N.J.; Kharche, S.; Tellez, J.O.; Greener, I.D.; Yamanushi, T.T.; Billeter, R.; Boyett, M.R.; Zhang, H.; Dobrzynski, H. Effects of streptozotocin-induced diabetes on connexin43 mRNA and protein expression in ventricular muscle. Mol. Cell. Biochem. 2008, 319, 105-114.
9. Stilli, D.; Lagrasta, C.; Berni, R.; Bocchi, L.; Savi, M.; Delucchi, F.; Graiani, G.; Monica, M.; Maestri, R.; Baruffi, S.; et al. Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. Basic Res. Cardiol. 2007, 102, 488-499.
10. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820.
11. Candido, R.; Forbes, J.M.; Thomas, M.C.; Thallas, V.; Dean, R.G.; Burns, W.C.; Tikellis, C.; Ritchie, R.H.; Twigg, S.M.; Cooper, M.E.; et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ. Res. 2003, 92, 785-792.
12. Shang, L.; Ananthakrishnan, R.; Li, Q.; Quadri, N.; Abdillahi, M.; Zhu, Z.; Qu, W.; Rosario, R.; Toure, F.; Yan, S.F.; et al. RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways. PLoS One 2010, 5, e10092.
13. Petrova, R.; Yamamoto, Y.; Muraki, K.; Yonekura, H.; Sakurai, S.; Watanabe, T.; Li, H.; Takeuchi, M.; Makita, Z.; Kato, I.; et al. Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes. J. Mol. Cell. Cardiol. 2002, 34, 1425-1431.
14. Ma, H.; Li, S.Y.; Xu, P.; Babcock, S.A.; Dolence, E.K.; Brownlee, M.; Li, J.; Ren, J. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J. Cell. Mol. Med. 2009, 13, 1751-1764.
15. Ripplinger, C.M.; Li, W.; Hadley, J.; Chen, J.; Rothenberg, F.; Lombardi, R.; Wickline, S.A.; Marian, A.J.; Efimov, I.R. Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ. Res. 2007, 101, 1049-1057.
16. Rucker-Martin, C.; Milliez, P.; Tan, S.; Decrouy, X.; Recouvreur, M.; Vranckx, R.; Delcayre, C.; Renaud, J.F.; Dunia, I.; Segretain, D.; et al. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc. Res. 2006, 72, 69-79.
17. Nygren, A.; Olson, M.L.; Chen, K.Y.; Emmett, T.; Kargacin, G.; Shimoni, Y. Propagation of the cardiac impulse in the diabetic rat heart: Reduced conduction reserve. J. Physiol. 2007, 580, 543-560.
18. De Mello, W.C. Impaired cell communication in the diabetic heart. The role of the renin angiotensin system. Mol. Cell. Biochem. 2007, 296, 53-58.
19. Zhang, M.; Kho, A.L.; Anilkumar, N.; Chibber, R.; Pagano, P.J.; Shah, A.M.; Cave, A.C. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: Involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 2006, 113, 1235-1243.
20. Sun, C.; Liang, C.; Ren, Y.; Zhen, Y.; He, Z.; Wang, H.; Tan, H.; Pan, X.; Wu, Z. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Basic Res. Cardiol. 2009, 104, 42-49.
21. Giles, T.D.; Ouyang, J.; Kerut, E.K.; Given, M.B.; Allen, G.E.; McIlwain, E.F.; Greenberg, S.S. Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat. Am. J. Physiol. 1998, 274, H295-H307.
22. Fernandes, R.; Girao, H.; Pereira, P. High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism. J. Biol. Chem. 2004, 279, 27219-27224.
23. Trudeau, K.; Muto, T.; Roy, S. Downregulation of mitochondrial connexin 43 by high glucose triggers mitochondrial shape change and cytochrome C release in retinal endothelial cells. Invest. Ophthalmol. Vis. Sci. 2012, 53, 6675-6681.
24. Liu, L.; Hu, X.; Cai, G.Y.; Lv, Y.; Zhuo, L.; Gao, J.J.; Cui, S.Y.; Feng, Z.; Fu, B.; Chen, X.M. High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling. Nephrol. Dial. Transplant. 2012, 27, 90-100.
25. Li, A.F.; Roy, S. High glucose-induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 2009, 50, 1400-1407.
26. 2+-ATPase. Diabetes 2004, 53, 463-473.
27. Lin, F.L.; Chang, C.I.; Chuang, K.P.; Wang, C.Y.; Liu, H.J. Advanced glycation end products down-regulate gap junctions in human hepatoma SKHep 1 cells via the activation of Src-dependent ERK1/2 and JNK/SAPK/AP1 signaling pathways. J. Agric. Food Chem. 2010, 58, 8636-8642.
28. Wang, C.Y.; Liu, H.J.; Chen, H.J.; Lin, Y.C.; Wang, H.H.; Hung, T.C.; Yeh, H.I. AGE-BSA down-regulates endothelial connexin43 gap junctions. BMC Cell Biol. 2011, 12, 19.
29. Rubenstein, D.A.; Maria, Z.; Yin, W. Glycated albumin modulates endothelial cell thrombogenic and inflammatory responses. J. Diabetes Sci. Technol. 2011, 5, 703-713.
30. Sakata, N.; Meng, J.; Takebayashi, S. Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J. Atheroscler. Thromb. 2000, 7, 169-176.
31. Chen, J.; Song, M.; Yu, S.; Gao, P.; Yu, Y.; Wang, H.; Huang, L. Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress. Mol. Cell. Biochem. 2010, 335, 137-146.
32. Li, J.; Liu, N.F.; Wei, Q. Effect of rosiglitazone on cardiac fibroblast proliferation, nitric oxide production and connective tissue growth factor expression induced by advanced glycation end-products. J. Int. Med. Res. 2008, 36, 329-335.
33. Kato, T.; Yamashita, T.; Sekiguchi, A.; Tsuneda, T.; Sagara, K.; Takamura, M.; Kaneko, S.; Aizawa, T.; Fu, L.T. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat. J. Cardiovasc. Electrophysiol. 2008, 19, 415-420.
34. Kang, R.; Tang, D.; Livesey, K.M.; Schapiro, N.E.; Lotze, M.T.; Zeh, H.J., III. The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury. Antioxid. Redox. Signal. 2011, 15, 2175-2184.
35. Li, J.; Schmidt, A.M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 1997, 272, 16498-16506.
36. Duffy, H.S.; Ashton, A.W.; O'Donnell, P.; Coombs, W.; Taffet, S.M.; Delmar, M.; Spray, D.C. Regulation of connexin43 protein complexes by intracellular acidification. Circ. Res. 2004, 94, 215-222.
37. Leithe, E.; Rivedal, E. Epidermal growth factor regulates ubiquitination, internalization and proteasome-dependent degradation of connexin43. J. Cell. Sci. 2004, 117, 1211-1220.
38. Jia, G.; Cheng, G.; Gangahar, D.M.; Agrawal, D.K. Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway. J. Mol. Cell. Cardiol. 2008, 44, 882-890.
39. Liang, J.Y.; Wang, S.M.; Chung, T.H.; Yang, S.H.; Wu, J.C. Effects of 18-glycyrrhetinic acid on serine 368 phosphorylation of connexin43 in rat neonatal cardiomyocytes. Cell. Biol. Int. 2008, 32, 1371-1379.
40. Musil, L.S.; Cunningham, B.A.; Edelman, G.M.; Goodenough, D.A. Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and-deficient cell lines. J. Cell. Biol. 1990, 111, 2077-2088.
41. Kwak, B.R.; Jongsma, H.J. Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol. Cell. Biochem. 1996, 157, 93-99.
42. Beardslee, M.A.; Lerner, D.L.; Tadros, P.N.; Laing, J.G.; Beyer, E.C.; Yamada, K.A.; Kleber, A.G.; Schuessler, R.B.; Saffitz, J.E. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ. Res. 2000, 87, 656-662.
43. Polontchouk, L.; Ebelt, B.; Jackels, M.; Dhein, S. Chronic effects of endothelin 1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J. 2002, 16, 87-89.
44. Huang, Y.S.; Tseng, Y.Z.; Wu, J.C.; Wang, S.M. Mechanism of oleic acid-induced gap junctional disassembly in rat cardiomyocytes. J. Mol. Cell. Cardiol. 2004, 37, 755-766.
45. Zhang, F.L.; Gao, H.Q.; Shen, L. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells. J. Cardiovasc. Pharmacol. 2007, 50, 434-440.
46. Zheng, F.; Cai, W.; Mitsuhashi, T.; Vlassara, H. Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: A potential AGE sequestration therapy for diabetic nephropathy? Mol. Med. 2001, 7, 737-747.
47. Bierhaus, A.; Schiekofer, S.; Schwaninger, M.; Andrassy, M.; Humpert, P.M.; Chen, J.; Hong, M.; Luther, T.; Henle, T.; Kloting, I.; et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001, 50, 2792-2808.
48. Blondel, B.; Roijen, I.; Cheneval, J.P. Heart cells in culture: A simple method for increasing the proportion of myoblasts. Experientia 1971, 27, 356-358.